🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BIONET Therapeutics Corp. (TPEX:7808)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.60
-2.60 (-8.07%)
At close: Nov 20, 2026

BIONET Therapeutics Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-69.24-97.43-86.26-37.34-12.52
Depreciation & Amortization
23.2211.773.240.58-
Loss (Gain) From Sale of Investments
0.13-0.14-0.71-0.03-
Stock-Based Compensation
17.2118.693.710.16-
Provision & Write-off of Bad Debts
1.220.010.01--
Other Operating Activities
0.16-1.64-4.99-1.6-
Change in Accounts Receivable
-10.79-13.24-10.27-1.17-
Change in Inventory
-24.81-0.56-29.15-0.37-
Change in Accounts Payable
3.27-9.1711.614.551.17
Change in Unearned Revenue
12.276.981.712.61-
Change in Other Net Operating Assets
2.7813.842.69-1.557.87
Operating Cash Flow
-25.49-57.48-124.39-34.16-3.47
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-23.67-81.19-46.56-12.1-
Sale (Purchase) of Intangibles
-4.32-2-0.46--
Investment in Securities
72.95219-707.09-478.99-
Other Investing Activities
0.04-0.06-0.68-0.01-
Investing Cash Flow
39.1135.75-754.8-491.09-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Repaid
--0.71---
Lease Payments
-3.32-0.71---
Net Debt Issued (Repaid)
-3.32-0.71---
Issuance of Common Stock
--855.85516.5796
Financing Cash Flow
-3.32-0.71855.85516.5796

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
10.377.56-23.33-8.6792.53

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-49.16-138.68-170.95-46.26-3.47
Free Cash Flow Growth
-----
Free Cash Flow Margin
-23.19%-89.77%-210.22%-861.52%-
Free Cash Flow Per Share
-0.70-1.98-2.98-3.06-3.17
Levered Free Cash Flow
-75.6-140.06-116.82-33.11-
Unlevered Free Cash Flow
-75.27-140.01-116.82-33.11-
Free Cash Flow After Leases
-52.48-139.39-170.95-46.26-3.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
0.040.08---
Cash Income Tax Paid
0.651.760.710.02-
Change in Working Capital
1.8111.26-39.44.079.04